Evidence supports scheduling early follow-up after heart failure (HF) hospitalization with a provider capable of managing hypervolemia. Often this service is provided by cardiologists or specialty nurse practitioners. Continuity or “familiar” providers may be better positioned to identify decompensating HF in patients who have advanced HF and/or multiple complicating medical problems. The objective of this study was to evaluate whether a clinical pharmacy specialist (CPS) service, covering the role of a “familiar” provider in an advanced HF specialty clinic (AHFC) during a staffing shortage, may prevent readmission metrics from worsening.
Methods:
We evaluated the entire, eligible concurrent cohorts, representing 175 AHFC-CPS and 273 control patient-admissions, respectively. Study- and disease-specific predictors for readmission were assessed. A matched cohort of 202 patient-admissions (101 AHFC-CPS:101 NO-CPS) were evaluated.
Results:
Subjects were predominantly white, elderly males. While overall “clinic [performance] profiling” outcomes for readmissions (p = 0.43) and mortality (p = 0.66) did not statistically differ between the AHFC-CPS and NO-CPS groups, an imbalance in severity of illness persisted. A survival curve and analysis were constructed, and the hazard ratio for all-cause mortality was 0.69 (p = 0.033).
Conclusions:
This retrospective project supports the premise that AHFC-CPS intervention may be a suitable alternative to maintain the volume status for AHFC patients during a staffing short-fall. More work needs to be done to determine intervention effect size, predictors for readmission, specifically in advanced cardiovascular disease, and to evaluate CPS opportunities in the provision of independent HF care, particularly for patients with advanced HF.
BenjaminEJMuntnerPAlonsoA, et al.American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics—2019 update: a report from the American Heart Association. Circulation. 2019;139(10):e56–e528. doi:10.1161/CIR.0000000000000659
2.
NutiSVQinLRumsfeldJS, et al.Association of admission to Veterans Affairs hospitals vs non-Veterans Affairs hospitals with mortality and readmission rates among older men hospitalized with acute myocardial infarction, heart failure, or pneumonia. JAMA. 2016;315(6):582–592. doi:10.1001/jama.2016.0278
3.
DharmarajanKHsiehAFLinZ, et al.Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia. JAMA. 2013;309(4):355–363. doi:10.1001/jama.2012.216476
4.
KrumholzHMHsiehADreyerRP, et al.Trajectories of risk for specific readmission diagnoses after hospitalization for heart failure, acute myocardial infarction, or pneumonia. PLoS One. 2016;11(10):e0160492. doi:10.1371/journal.pone.0160492
5.
GoldfieldNIMcCulloughECHughesJS, et al.Identifying potentially preventable readmissions. Health Care Financ Rev. 2008;30(1):75–91.
6.
AlbertNMBarnasonSDeswalA, et al.American Heart Association Complex Cardiovascular Patient and Family Committee of the Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Quality of Care and Outcomes Research. Transitions of care in heart failure: a scientific statement from the American Heart Association. Circ Heart Fail. 2015;8(2):384–409. doi:10.1161/HHF.0000000000000006
7.
YancyCWJessupMBozkurtB, et al.American College of Cardiology Foundation. American Heart Association task force on practice guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2013;62(16):e147–239. doi:10.1161/CIR.0b013e31829e8776
8.
BakerHOliver-McNeilSDengL, et al.Regional hospital collaboration and outcomes in Medicare heart failure patients: see you in 7. J Am Coll Cardiol HF. 2015;3(10):765–773. doi:10.1016/j.jchf.2015.06.007
9.
DeVoreADCoxMEapenZJ, et al.Temporal trends and variation in early scheduled follow-up after a hospitalization for heart failure: findings from get with the guidelines-heart failure. Circ Heart Fail. 2016;9(1):e002344. doi:10.1161/CIRCHEARTFAILURE.115.002344
10.
ReddyAWongECanamucioA, et al.Association between continuity and team-based care and health care utilization: an observational study of Medicare-eligible veterans in VA patient aligned care team. Health Serv Res. 2018;53(Suppl 3):5201–5218. doi:10.1111/1475-6773.13042
11.
KatzDAMcCoyKDVaughan-SarrazinMS. Does greater continuity of Veterans administration primary care reduce emergency department visits and hospitalization in older veterans?J Am Geriatr Soc. 2015;63(12):2510–2518. doi:10.1111/jgs.13841
12.
BarkerISteventonADeenySR. Association between continuity of care in general practice and hospital admissions for ambulatory care sensitive conditions: cross sectional study of routinely collected, person level data. BMJ. 2017;356:j84. doi:10.1136/bmj.j84
13.
TungYCChangGMChangHY, et al.Relationship between early physician follow-up and 30-day readmission after acute myocardial infarction and heart failure. PLoS One. 2017;12(1):e0170061. doi:10.1371/journal.pone.0170061
14.
SidhuRSYoungsonEMcAlisterFA. Physician continuity improves outcomes for heart failure patients treated and released from the emergency department. J Am Coll Cardiol HF. 2014;2(4):368–376. doi:10.1016/j.jchf.2014.03.006
15.
DunnSPBirtcherKKBeaversCJ, et al.The role of the clinical pharmacist in the care of patients with cardiovascular disease. J Am Coll Cardiol. 2015;66(19):2129–2139. doi:10.1016/j.jacc.2015.09.025
16.
Mildfred-LaForestSKChowSLDiDomenicoR, et al.Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network. J Card Fail. 2013;19(5):354–369. doi:10.1016/j.cardfail.2013.02.002
17.
ParajuliDRKourbelisCFranzonJ, et al.Effectiveness of the pharmacist-involved multidisciplinary management of heart failure to improve hospitalizations and mortality rates in 4630 patients: a systematic review and meta-analysis of randomized controlled trials. J Card Fail. 2019;25(9):744–756. doi:10.1016/j.cardfail.2019.07.455
18.
McKayCParkCChangJ, et al.Systematic review and meta-analysis of pharmacist-led transitions of care services on the 30-day all-cause readmission rate of patients with congestive heart failure. Clin Drug Investig. 2019;39(8):703–712. doi:10.1007/s40261-019-00797-2
19.
OurthHGroppiJMorrealeAP, et al.Clinical pharmacist prescribing activities in the Veterans Health Administration. Am J Health Syst Pharm. 2016;73(18):1406–1415. doi:10.2146/ajhp150778
20.
ShahKSXuHMatsouakaRA, et al.Heart failure with preserved, borderline, and reduced ejection fraction. 5-year outcomes. J Am Coll Cardiol. 2017;70(20):2476–2486. doi:10.1016/j.jacc.2017.08.074
21.
DesaiSAStevensonLW. Rehospitalization for heart failure: predict or prevent?Circulation. 2012;126(4):501–506. doi:10.1161/CIRCULATIONAHA.112.125435
22.
MikrinKAEnomotoLMCaputoG, et al.Risk factors for 30-day readmission in patients with congestive heart failure. Heart Lung. 2017;46(5):357–362. doi:10.1016/j.hrtlng.2017.06.005
23.
KrishnamurthiMFrancisJFihnSD, et al.Leading causes of cardiovascular hospitalization in 8.45 million US veterans. PLoS One. 2018;13(3):e0193996. doi:10.1371/journal.pone.0193996
24.
ShamsISaeedeAYangK. A predictive analytics approach to reducing 30-day avoidable readmission among patients with heart failure, acute myocardial infarction, pneumonia, or COPD. Health Care Manag Sci. 2015;18(1):19–34. doi:10.1007/s10729-014-9278-y
25.
ManemannSMChamberlainAMBoydC, et al.Multimorbidity in heart failure: effect on outcomes. J Am Geriatr Soc. 2016;64(7):1469–1474. doi:10.1111/jgs.14206
26.
WileyJFChanYKAhamedY, et al.Multimorbidity and the risk of all-cause 30-day readmission in the setting of multidisciplinary management of chronic heart failure. A retrospective analysis of 830 hospitalized patients in Australia. J Cardiovasc Nurs.2018;33(5):437–445. doi:10.1097/JCN.0000000000000391
27.
AroraSPatelPLahewalaS, et al.Etiologies, trends, and predictors of 30-day readmission in patients with heart failure. Am J Cardiol. 2017;119(5):760–769. doi:10.1016/j.amjcard.2016.11.022
28.
CoxZLLaiPLewisCM, et al.Customizing national models for a medical center’s population to rapidly identify patients at high risk of 30-day all-cause hospital readmission following a heart failure hospitalization. Heart Lung. 2018;47(4):290–296. doi:10.1016/j.hrtlng.2018.05.012
29.
DavidsonBAMerraMSengerS, et al.Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality. Eur J Heart Fail. 2016;18(8):1041–1050. doi:10.1002/ejhf.540
30.
LoopMSVan DykeMKChenL, et al.Comparison of length of stay, 30-day mortality, and 30-day readmission rates in Medicare patients with heart failure and with reduced versus preserved ejection fraction. Am J Cardiol. 2016;118(1):79–85. doi:10.1016/j.amjcard.2016.04.015
31.
ChengRKCoxMNeelyML. Outcomes in patients with heart failure preserved, borderline, and reduced ejection fraction in the Medicare population. Am Heart J. 2014;168(5):721–730. doi:10.1016/j.ahj.2014.07.008
LeeKKThomasRTanTC, et al.The Heart Failure Readmission Intervention by Variable Early Follow-up (THRIVE) study: a pragmatic randomized trial. J Card Fail. 2018;24(11):808–809. doi:10.1016/j.cardfail.2018.11.004
34.
HaleGMHassanSLHummelSL, et al.Impact of a pharmacist-managed heart failure postdischarge (Bridge) Clinic for Veterans. Ann Pharmacother. 2017;51(7):555–562. doi:10.1177/1060028017698974
35.
YoonJFonarowGCGroeneveldPW, et al.Patient and facility variation in costs of VA heart failure patients. J Am Coll Cardiol HF. 2016;4(7):551–558. doi:10.1016/j.jchf.2016.01.003
36.
VA Office of Inspector General. OIG determination of Veterans Health Administration’s occupational staffing shortages. June 14, 2018. Accessed May 10, 2021. https://www.va.gov/oig/pubs/VAOIG-18-01693-196.pdf
37.
NarangASinhaSSRajagopalanB, et al.The supply and demand in the cardiovascular workforce. Striking the right balance. J Am Coll Cardiol. 2016;68(15):1680–1689.
